Please login to the form below
Data by
17
Revenue 2014Novo Nordisk
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novo Nordisk's 2013 sales performance.
FDA panel backs CV claims for Novo Nordisk's Victoza
FDA panel backs CV claims for Novo Nordisk's Victoza. LEADER trial shows the diabetes treatment reduces risk of cardiovascular death by 13%. ... provide benefits beyond HbA1c control in this population," said Todd Hobbs, Novo Nordisk's chief medical
Asian patient groups give pharma above average marks for reputation
Meanwhile, GSK was placed first for the provision of ‘high-quality’patient information and Novo Nordisk took first position for patient safety, high quality products and integrity.
Novo says real-world data backs its insulin switching
Novo says real-world data backs its insulin switching. EU-TREAT study shows Tresiba improved blood glucose control. ... Novo Nordisk's battle for supremacy in the basal insulin sector opened another front over the weekend as the firm presented real-world
Novo Nordisk wins European approval for Refixia
Novo Nordisk wins European approval for Refixia. Plans to launch the haemophilia B treatment in the fourth quarter. ... Novo Nordisk has won EU approval for its new haemophilia drug Reflixia and is planning its first European launches in the fourth
Novo says real-world data back its insulin switching
Novo says real-world data back its insulin switching. EU-TREAT study shows Tresiba improved blood glucose control. ... Novo Nordisk's battle for supremacy in the basal insulin sector opened another front over the weekend as the firm presented real-world
| Global revenue 2014 |
|---|
| 1: Novartis |
| 2: Pfizer |
| 3: Roche |
| 4: Sanofi |
| 5: Merck & Co. |
| 6: Johnson & Johnson |
| 7: GlaxoSmithKline |
| 8: AstraZeneca |
| 9: Gilead Sciences |
| 10: Takeda |
| 11: AbbVie |
| 12: Amgen |
| 13: Teva |
| 14: Lilly |
| 15: Bristol-Myers Squibb |
| 16: Bayer |
| 17: Novo Nordisk |
| 18: Astellas |
| 19: Boehringer Ingelheim |
| 20: Actavis |
| 21: Otsuka |
| 22: Daiichi Sankyo |
| 23: Biogen Idec |
| 24: Baxter |
| 25: Merck KGaA |
| US revenue 2014 |
|---|
| 1: Gilead Sciences |
| 2: Johnson & Johnson |
| 3: Pfizer |
| 4: Roche |
| 5: Novartis |
| 6: Amgen |
| 7: Merck & Co. |
| 8: Sanofi |
| 9: AbbVie |
| 10: Actavis |
| 11: AstraZeneca |
| 12: GlaxoSmithKline |
| 13: Lilly |
| 14: Bristol-Myers Squibb |
| 15: Novo Nordisk |
| Metabolic revenue 2014 |
|---|
| 1: Novo Nordisk |
| 2: Sanofi |
| 3: Merck & Co. |
| 4: Lilly |
| 5: AstraZeneca |
| 6: Takeda |
| 7: Novartis |
| 8: Amgen |
| 9: Bayer |
| 10: Merck KGaA |
| 11: Salix Pharmaceuticals |
| 12: AbbVie |
| 13: Dainippon Sumitomo Pharma |
| 14: Kyowa Hakko Kirin |
| 15: Mitsubishi Tanabe |
| Biologic revenue 2014 |
|---|
| 1: Roche |
| 2: Amgen |
| 3: Novo Nordisk |
| 4: AbbVie |
| 5: Sanofi |
| 6: Johnson & Johnson |
| 7: Pfizer |
| 8: Merck & Co. |
| 9: Lilly |
| 10: Biogen Idec |
| 11: Merck KGaA |
| 12: GlaxoSmithKline |
| 13: Bristol-Myers Squibb |
| 14: Novartis |
| 15: Bayer |
Data by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
Featured jobs
-
Brand Communications Manager
-
A competitive salary plus bonus
- Senior Director, Healthcare PR, Home Counties
-
Competitive
- 6-12 MONTH FREELANCE OPPORTUNITY - ACCOUNT DIRECTOR or SENIOR AC...
-
SUPERB DAY RATE AVAILABLE
-
Principal Medical Writer
-
Great salary and benefits
-
*Multi-Channel Creative Designer*
-
Competitive Salary
-
*Design Manager*
-
Competitive Salary
- Senior Corporate Communications Manager
-
Competitive Salary
-
Senior Medical Writer
-
Great salary and benefits
- Account Director or Senior Account Director, Healthcare Advertis...
-
£55, 000 - £65, 000 benefits
-
Account Director - Med Comms
-
Great salary and benefits
- Account Director - Healthcare Advertising - London
-
£50000 - £68000
- Account Manager, Medical Communications
-
£30, 000-£40, 000
- Senior Account Manager – Healthcare PR
-
Salary TBC
- FREELANCE *Client Service/ Project Manager*
-
Competitive Salary
-
Head of Marketing Insulin
-
Competitive Salary
-
Scientific Director
-
£70, 000 - £85, 000
- Account Manager, Healthcare PR, Global and UK
-
£33, 000 – £40, 000
-
Director – Healthcare PR/ Policy
-
Salary TBC
Subscribe to our email news alerts
- Sanofi continues pharma's trend of ditching the corporate blog
- Bayer wins FDA approval for MS electronic autoinjector and app
- Warning sounded on pharma's long-term sales prospects
- Facing the new wave of biosimilars
- Sandoz joins Europe's MabThera biosimilar push
- FDA panel backs CV claims for Novo Nordisk's Victoza
- The new pharma marketing playbook
- PEGASUS SHOWREEL 2017
- Alzheon says data backs potential of Alzheimer's candidate
- Shift to value-based medicine will boost mHealth uptake
- Ashfield to host global webinar on Patient Service Team on 10 July
- Pharma needs to evolve from customer-centricity to stakeholder-centricity
PMHub
Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...
Latest intelligence
- The new pharma marketing playbook
- Learn about the 5 areas that must be in your pharma marketing playbook...
- Pharma needs to evolve from customer-centricity to stakeholder-centricity
- Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders....
- 5 health behavioural factors to incorporate in your marketing
- Achieve real health behaviour change by including these elements in your pharmaceutical marketing....
Quick links
Infographics
